Medical Products Company
MedImmune has acquired 7 companies of its own. A total of 2 acquisitions came from private equity firms.
MedImmune’s largest acquisition to date was in 2013, when it acquired Amplimmune for $500M. MedImmune has acquired in 3 different US states, and 3 countries. The Company’s most targeted sectors include life science (86%).
Join Mergr and gain access to MedImmune’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.
M&A Total Activity6
- M&A Buy Activity Activity7
- Total Sectors Invested 1
- Total Countries Invested 3
- M&A Buy/Sell Connections 3